Promising Emerging Classes of Therapies in Non-Small Cell Lung Cancer
14 Visninger
• 07/14/23
0
0
Indlejre
administrator
Abonnenter
David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, each provide their opinion on the most promising emerging class of therapeutics in non-small cell lung cancer (NSCLC).
More from this Peer Exchange discussion: http://www.onclive.com/peer-ex....change/nsclc-advance
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer